Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Respiratory Disease Testing market, 2015 - 2021 (USD Billion)
2.2. Global Respiratory Disease Testing market: Snapshot
Chapter 3. Respiratory Disease Testing Market Dynamics
3.1. Introduction
3.2. Value chain analysis
3.3. Market drivers
3.3.1. Increase in Prevalence of Respiratory Diseases
3.3.2. Changing Lifestyle and Improvement in Medical Facilities
3.4. Market restraints
3.4.1. Low adoption rate of advanced spirometers and digital radiography systems
3.5. Opportunities
3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific
3.6. Porters five forces analysis
3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers
3.6.3. Threat from new entrants
3.6.4. Threat from new substitutes
3.6.5. Degree of competition
3.7. Market attractiveness analysis
3.7.1. Market attractiveness analysis, by product segment
3.7.2. Market attractiveness analysis, by end-user segment
3.7.3. Market attractiveness analysis, by regional segment
Chapter 4. Global Respiratory Disease Testing Market Competitive Landscape
4.1. Company market share, 2015 (Subject to data availability)
4.2. Price trend analysis
Chapter 5. Global Respiratory Disease Testing Market Product Segment Analysis
5.1. Global Respiratory Disease Testing market: Product segment overview
5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021
5.2. Lung Volume
5.2.1. Global Lung Volume market , 2015 2021 (USD Billion)
5.3. Imaging
5.3.1. Global Imaging market, 2015 2021 (USD Billion)
5.4. Spirometry
5.4.1. Global Spirometry market, 2015 2021 (USD Billion)
5.5. Peak Flow
5.5.1. Global Peak Flow market, 2015 2021 (USD Billion)
5.6. Blood Gas
5.6.1. Global Blood Gas market, 2015 2021 (USD Billion)
5.7. Others
5.7.1. Global Other Tests market, 2015 2021 (USD Billion)
Chapter 6. Global Respiratory Disease Testing Market End-user Segment Analysis
6.1. Global Respiratory Disease Testing market: End-user segment overview
6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021
6.2. Hospitals
6.2.1. Global Hospitals market , 2015 2021 (USD Billion)
6.3. Physician Offices
6.3.1. Global Physician Offices market, 2015 2021 (USD Billion)
6.4. Clinical Laboratories
6.4.1. Global Clinical Laboratories market, 2015 2021 (USD Billion)
Chapter 7. Global Respiratory Disease Testing Market Regional Segment Analysis
7.1. Global Respiratory Disease Testing Market: Regional Overview
7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021
7.2. North America
7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.3. Europe
7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.3.3. UK
7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.3.4. France
7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion)
7.3.5. Germany
7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015 2021, (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.4.3. China
7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.4.4. Japan
7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.4.5. India
7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.5. Latin America
7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
7.6. Middle East And Africa
7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015 2021, (USD Billion)
7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015 2021 (USD Billion)
Chapter 8. Company Profile
8.1. ndd Medical Technologies, Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Portfolio
8.1.4. Business Strategy
8.1.5. Recent Developments
8.2. Carestream Health, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Portfolio
8.2.4. Business Strategy
8.2.5. Recent Developments
8.3. SDI Diagnostics
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Portfolio
8.3.4. Business Strategy
8.3.5. Recent Developments
8.4. Nihon Kohden Corporation
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Portfolio
8.4.4. Business Strategy
8.4.5. Recent Developments
8.5. CareFusion Corporation
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Portfolio
8.5.4. Business Strategy
8.5.5. Recent Developments
8.6. Smiths Medical
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Portfolio
8.6.4. Business Strategy
8.6.5. Recent Developments
8.7. COSMED
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Portfolio
8.7.4. Business Strategy
8.7.5. Recent Developments
8.8. Perkin Elmer, Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Portfolio
8.8.4. Business Strategy
8.8.5. Recent Developments
8.9. Philips Healthcare
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Portfolio
8.9.4. Business Strategy
8.9.5. Recent Developments
8.10. MGC Diagnostic Corporation
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Portfolio
8.10.4. Business Strategy
8.10.5. Recent Developments
8.11. Futuremed America, Inc.
8.11.1. Overview
8.11.2. Financials
8.11.3. Product Portfolio
8.11.4. Business Strategy
8.11.5. Recent Developments
8.12. GE Healthcare
8.12.1. Overview
8.12.2. Financials
8.12.3. Product Portfolio
8.12.4. Business Strategy
8.12.5. Recent Developments